Journal Reviews

Comparison of pathological stage in patients treated with and without neoadjuvant chemotherapy for high-risk UTUC

1 March 2019 | | Urologic Oncology | carcinoma, chemotherapy, kidney neoplasms, neoadjuvant therapy, transitional cell, ureteral neoplasms

High-risk upper tract urothelial carcinoma (UTUC) has been associated with poor survival outcomes. The authors evaluated the role of neoadjuvant chemotherapy in high-risk cases prior to radical nephroureterectomy (RNU) in terms of pathological stage of the final surgical specimen. A...

Comparing intravesical chemohyperthermia with Mitomycin C versus BCG in treating bladder cancer

1 July 2016 | | Urologic Oncology | BCG, Device-assisted therapy, Hyperthermia, Intravesical chemotherapy, Mitomycin-C, Non–muscle-invasive bladder cancer, Radiofrequency, Randomised controlled trial, Recurrence rate, Thermochemotherapy

In the advent of the recent Bacillus Calmette–Guérin (BCG) crisis, the importance of alternative adjuvant treatments for intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) has been highlighted. Chemohyperthermia (CHT) has emerged as an option, however there remains a lack of...